secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001104659-25-061203
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics files $2.5M at-the-market equity offering through A.G.P.
--------------------------------------------------------------------------

- Up to $2,534,352 of common stock registered for sale via ATM method with A.G.P./Alliance Global Partners.
- Sales agent commission rate set at up to 3.0% of gross proceeds per share sold.
- No minimum sale requirement; agent uses commercially reasonable efforts on a principal or agency basis.
- Proceeds will be used for general corporate purposes; no escrow or trust arrangement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465925061203/0001104659-25-061203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465925061203/tm2518362d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer